Promising c. diff drug trial halted early
NCT ID NCT06536465
First seen Nov 17, 2025 · Last updated May 22, 2026 · Updated 19 times
Summary
This study tested a new medicine called REC-3964 in adults who had a C. diff infection and were at high risk for it coming back. The goal was to see if the drug could safely prevent another infection. Only 3 people took part before the study was stopped early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
GANJ - Toms River - Ocean Family Gastroenterology
Toms River, New Jersey, 08755, United States
-
Southern Star Research Institute, LLC
San Antonio, Texas, 78229, United States
Conditions
Explore the condition pages connected to this study.